Cephalalgia : an international journal of headache
-
Randomized Controlled Trial
Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
To investigate the efficacy, safety and tolerability of intradermal and/or submucosal administration of botulinum toxin type A (BTX-A) for patients with trigeminal neuralgia (TN). ⋯ BTX-A may be an efficient, safe and novel strategy for TN treatment.
-
Few clinic-based studies report an association between migraine and restless legs syndrome (RLS); however, population-based data are unavailable. ⋯ Our data suggest an association between migraine and RLS at the population level. The association is similar for migraine with and without aura and for new reports of migraine during follow-up.